Daitaro Yoshikawa

Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma

Daitaro Yoshikawa, Hidenori Ojima, Motoki Iwasaki et al. · British Journal of Cancer · 2007 · 410 citations · Full text

Medicine, Oncology, Pathology +17

Vandetanib (ZD6474), an inhibitor of VEGFR and EGFR signalling, as a novel molecular-targeted therapy against cholangiocarcinoma

Daitaro Yoshikawa, Hidenori Ojima, Akiko Kokubu et al. · British Journal of Cancer · 2009 · 95 citations · Full text

Medicine, Oncology, Pharmacology +17

Portal annular pancreas, a notable pancreatic malformation: Frequency, morphology, and implications for pancreatic surgery

Hidenori Karasaki, Yusuke Mizukami, Akira Ishizaki et al. · Surgery · 2009 · 74 citations · Full text

Medicine, Anatomy, Surgery +16

A malignant nonfunctioning pancreatic endocrine tumor with a unique pattern of intraductal growth

Mitsuhiro Inagaki, Kazunori Watanabe, Daitaro Yoshikawa et al. · Journal of Hepato-Biliary-Pancreatic Surgery · 2007 · 29 citations

Medicine, Oncology, Pathology +16

Establishment of six new human biliary tract carcinoma cell lines and identification of MAGEH1 as a candidate biomarker for predicting the efficacy of gemcitabine treatment

Hidenori Ojima, Daitaro Yoshikawa, Hiroko Shimizu et al. · Cancer Science · 2009 · 26 citations · Full text

Medicine, Oncology, Pharmacology +15